Importance of androgen-deprivation therapy during enzalutamide treatment in men with metastatic castration-resistant prostate cancer following chemotherapy: results from retrospective, multicenter data

Importance of androgen-deprivation therapy during enzalutamide treatment in men with metastatic castration-resistant prostate cancer following chemotherapy: results from retrospective, multicenter dataImportance of androgen-deprivation therapy during enzalutamide treatment in men with metastatic castration-resistant prostate cancer following chemotherapy: results from retrospective, multicenter data, Published online: 13 September 2018; doi:10.1038/s41391-018-0088-zImportance of androgen-deprivation therapy during enzalutamide treatment in men with metastatic castration-resistant prostate cancer following chemotherapy: results from retrospective, multicenter data

Source: Prostate Cancer and Prostatic Diseases - September 13, 2018 Category: Urology & Nephrology Authors: Chang Wook Jeong Minyong Kang Seung Il Jung Tae-Hwan Kim Sung Woo Park Jae Young Joung Seong Soo Jeon Jun Hyuk Hong Ji Youl Lee Byung Ha Chung Hanjong Ahn Choung-Soo Kim Dong Deuk Kwon Cheol Kwak Source Type: research